In the 10-K report, Liquidia Corporation reported a net loss of $130.4 million for the year ended December 31, 2024, compared ...

Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).

Fitness. The viral oregano infusion that can be taken every day to improve intestinal transit Health. Say goodbye to insomnia: the best treatment for sleep from adulthood onwards according to ...

The global smart syringes market is poised for substantial growth, projected to escalate from a valuation of US$ 10.22 billion in 2024 to US$ 24.37 billion by 2033, reflecting an impressive CAGR of 10 ...

Post the infusion, core liquidity, taking into account banking system liquidity along with government cash balances, will remain in a "comfortable surplus" of 1.6 trillion rupees by March-end from ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The growth in Remodulin revenues resulted from an increase in U.S. Remodulin revenues and, to a lesser extent, an increase in international Remodulin revenues, driven, in both cases, by an ...